Resultados del tratamiento planificado de la tuberculosis en condiciones de rutina con un esquema terapeutico que incluye isoniacida, rifampicina y estreptomicina.

Gonzalez Montaner, L. J; Palma Beltran, O. R; Abbate, Eduardo H; Dambrosi, A; Mosca, C.
Rev. argent. tuberc. enfermedades pulm. salud pública ; 43(2): 5-9, 1982.
Artículo en Español | LILACS | ID: lil-8939

Documentos relacionados

  1. A Shorter Regimen for Rifampin-Resistant Tuberculosis.
  2. A Shorter Regimen for Rifampin-Resistant Tuberculosis.
  3. A Shorter Regimen for Rifampin-Resistant Tuberculosis. Reply.
  4. Photoelectrochemical sensing of isoniazid and streptomycin based on metal Bi-doped BiOI microspheres grown on book-shape layers of Ti<sub>3</sub>C<sub>2</sub> heterostructures.
  5. Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study.
  6. High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
  7. Reply to Decroo <i>et al.</i>: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
  8. [Recommendations for contact tracing for tuberculosis - update 2023].
  9. [Recommendations for Contact Tracing for Tuberculosis - Update 2023].
  10. Optimising pyrazinamide for the treatment of tuberculosis.